Physiomics (LON:PYC) Stock Price Down 7.4% – Should You Sell?

Shares of Physiomics Plc (LON:PYC) fell 7.4% during mid-day trading on Thursday. The stock traded as low as GBX 0.40 and last traded at GBX 0.44. 15,677,377 shares traded hands during mid-day trading, an increase of 182% from the average daily volume of 5,550,020 shares. The stock had previously closed at GBX 0.47.

Physiomics Stock Performance

The stock has a market cap of £1.99 million, a price-to-earnings ratio of -2.93 and a beta of 1.05. The stock has a fifty day simple moving average of GBX 0.50 and a two-hundred day simple moving average of GBX 0.49.

Physiomics (LON:PYC) last announced its earnings results on Tuesday, October 13th. The company reported GBX (0.20) earnings per share (EPS) for the quarter. Physiomics had a negative return on equity of 152.03% and a negative net margin of 74.06%. Equities analysts expect that Physiomics Plc will post -0.13 earnings per share for the current fiscal year.

Physiomics Company Profile

Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. It also develops technology for use in the field of personalized medicine. The company was incorporated in 2001 and is based in Oxford, the United Kingdom.